AI 聊天
正在載入 ELMD 的資料(首次造訪,需要幾秒鐘)。

Electromed, Inc.

ELMD · NYSE American · USD

28.10 -0.40 (-1.40%)

收盤價: Oct 02, 2026, 4:00 PM EDT

28.10 +0.18%

盤後: 4:01 PM

市值
$232.9M
成交量
84.8K
下次財報日期
Nov 11, 2026

Electromed, Inc.(ELMD)股價、分析與資料

間隔:1D
正在載入K線和訊號…

內在價值

估值模型屬於 Pro 功能。登入或升級後可查看完整分析。

查看方案 →

分析師預測

股票預測 →

目標價

$47.00 – $50.00

中位數 $48.50 · 72.60% 上漲空間

12個月目標價 · 2 位分析師

分析師共識: n/a

您正在查看免費總覽

建立免費帳戶,探索更多關於此標的的研究資料。

財務表現

查看財務 →
營收 (ttm)
$73.78M

正在載入...

最新財報

已通報較預期YoY 變更
營收$19.42Mn/a+11.64%
EPS$0.39+$0.07+85.71%

下次財報

盤中。

估計 · 升級 →

查看財報詳情 →

指標

買價
28
市值
233M
淨利(ttm)
11.3M
0.46
1.3
21.62
46.07
P/B (ttm)
4.36
P/S (ttm)
3.16
財報日期
Nov 11, 2026
賣價
28.09
成交量
84,750
20 日平均成交量
107,082
開盤價
28.53
前收盤價
28.50
當日區間
27.67 - 28.75
52 週範圍
23.01 - 47.40
目標價
48.5 (72.60%)
股利
n/a
除息日
n/a

關於 Electromed, Inc.

查看公司資料 →
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. Medical Devices · Healthcare

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

類股 Healthcare
IPO 日期 Aug 13, 2010
員工 195
證券交易所 NYSE American
股票代號 ELMD